BioSpace News Archive

Pharm Country

Applied DNA Expands BioPharm Vertical With Two New Research Pilots of DNA Therapeutics

These pilots will be developed using the Company’s proprietary and patented large-scale PCR (polymerase chain reaction) DNA production processes and devices.

November 30, 2017

·

8 min read

Drug Development

ArmaGen’s AGT-181 Granted Fast Track Designation for the Treatment of Hurler Syndrome (MPS I)

The data suggested that AGT-181 improves neurocognitive function in patients with MPS I, demonstrating the ability of ArmaGen’s proprietary drug delivery technology to transport biopharmaceuticals across the blood-brain barrier.

November 30, 2017

·

3 min read

Drug Development

New and Updated Data for Merck’s KEYTRUDA (pembrolizumab) and Updated Data on LYNPARZA (olaparib) in Multiple Breast Cancer Subtypes to Be Presented at the 2017 San Antonio Breast Cancer Symposium (SABCS)

In addition to the presentation of KEYTRUDA data at SABCS, updated data on LYNPARZA being co-developed and co-commercialized with AstraZeneca, will be presented.

November 30, 2017

·

33 min read

Drug Development

Solid Biosciences Initiates Clinical Trial for Gene Transfer Candidate SGT-001 in Patients With Duchenne Muscular Dystrophy

Interim analysis anticipated in the first half of 2019.

November 30, 2017

·

5 min read

Genetown

Enanta Announces That AbbVie’s MAVIRET (glecaprevir/pibrentasvir) Is Now Available in Japan for the Treatment of Chronic Hepatitis C Across All Major Genotypes (GT1-6)

With the reimbursement approval in Japan, Enanta has now earned a $15 million milestone payment, which it expects to receive this quarter.

November 30, 2017

·

5 min read

Biotech Beach

Epic Sciences Launches Metastatic Breast Cancer Circulating Tumor Cell Panel

The Epic breast cancer panel is the most comprehensive breast cancer biomarker panel available for CTCs within a blood sample.

November 30, 2017

·

2 min read

Ampio Pharma Announces Engagement of LaVoieHealthScience for Integrated Public and Investor Relations

LaVoieHealthScience will immediately begin designing and executing a strategic communications plan to extend Ampio’s reach.

November 30, 2017

·

3 min read

Pharm Country

MonoSol Rx Changes Name to Aquestive Therapeutics and Expands CNS Product Portfolio

The new name reflects the company’s expanded capabilities in developing and commercializing a proprietary portfolio of medicines, initially focused on the CNS.

November 30, 2017

·

2 min read

Neptune Receives Nasdaq Notification Confirming that it has Regained Compliance with Minimum Bid Requirements

Neptune, announces that on November 28, 2017 it received notification from Nasdaq Listing Qualifications Department confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) - bid price.

November 30, 2017

·

1 min read

Pharm Country

Navitas Brings End-to-End R&D Solutions to the Generic Drug Industry

Navitas Life Sciences has conducted more than 1000 projects with over 100 MAH approved in six continents.

November 30, 2017

·

3 min read